GSK is a global biopharma company. Our purpose is to unite science, technology and talent to get ahead of disease together and positively impact the health of 2.5 billion people. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. GSK focuses on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
GSK launched its new legal entity in Vietnam in 2022, GSK Pharma Viet Nam Company Limited, establishing its USD 200 million investment capital in the country, aims to growing sustainably and responsibly in Vietnam. GSK Vietnam expressed its commitment to continue to work together with strategic healthcare partners in preventing and treating diseases with innovative vaccines and general medicines, positively impact the health of more than one third of Vietnamese population in the next three years.